Wenlin Chen

Peking University Cancer Hospital Yunnan

H指数:19

被引数:1,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vitamin D regulation of gut microbiota-derived butyrate as a potential inhibitor of breast cancer proliferation

维生素D对肠道菌群衍生丁酸盐的调控及其作为乳腺癌增殖潜在抑制剂的机制

Gene

IF2.4

2025-11-040

PRE

Propionylated high-amylose maize starch protects gut barrier function via GPR41/43-IL-22-STAT3 signaling to alleviate alcoholic liver disease

丙酸化高直链玉米淀粉通过GPR41/43-IL-22-STAT3信号通路保护肠道屏障功能，以缓解酒精性肝病

Food Bioscience

IF5.9

2025-10-070

PRE

Gut microbiota, blood metabolites, & pan-cancer: a bidirectional Mendelian randomization & mediation analysis

肠道菌群，血液代谢物和泛癌症: 双向孟德尔随机化和中介分析

AMB EXPRESS

IF3.7

2025-04-020

OAAI

Genetic analysis reveals the shared genetic architecture between breast cancer and atrial fibrillation

遗传分析揭示了乳腺癌和心房颤动之间共享的遗传结构。

FRONTIERS IN GENETICS

IF2.8

2025-03-250

Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis

转铁蛋白通过使TCR与CD3信号复合体解离来促进转移。

Research

IF10.7

2025-01-130

Exploring the genetic associations and causal relationships between antibody responses, immune cells, and various types of breast cancer

探索抗体反应，免疫细胞和各种类型的乳腺癌之间的遗传关联和因果关系

SCIENTIFIC REPORTS

IF3.9

2024-11-190

OAAI

Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-10-250

OAAI

Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies

通过联合cGAS-STING通路策略靶向重塑肿瘤微环境来增强免疫治疗效果

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-05-165

OAAI

Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)

乳腺癌术中放疗: 肿瘤微环境的改变和随后的生物学结果 (综述)

MOLECULAR MEDICINE REPORTS

IF3.5

2023-10-255

OAAI

RETRACTION: MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1 (Retraction of Vol 38, Pg 1569, 2017)

ONCOLOGY REPORTS

IF3.9

2023-03-130

OAAI

The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-1610

OAAI

A comparison of Chinese multicenter breast cancer database and SEER database

SCIENTIFIC REPORTS

IF3.9

2022-06-214

OAAI

Anticarin-β shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-05-0114

OAAI

RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis

NPJ BREAST CANCER

IF7.6

2021-05-1217

OAAI

USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5

USP3通过去泛素化KLF5促进乳腺癌细胞增殖

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-11-0156

OAAI

RETRACTED: MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1 (Retracted article. See vol. 49, 2023)

ONCOLOGY REPORTS

IF3.9

2017-07-1242

OAAI

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation

CELL DISCOVERY

IF12.5

2017-04-18119

OAAI

Thioredoxin Protects Skin Flaps from Ischemia-Reperfusion Injury: A Novel Prognostic and Therapeutic Target

PLASTIC AND RECONSTRUCTIVE SURGERY

IF3.4

2016-02-0128

PREAI

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression

THERANOSTICS

IF13.3

2016-01-01125

OAAI

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5

NATURE COMMUNICATIONS

IF15.7

2015-09-30155

OAAI

Wenlin Chen

个人简介

教育背景

工作经历

荣誉奖项

研究方向